SCHEMBL5590140

SCHEMBL5590140

CCCCc1c(Cl)cc(OC(=O)O)c(O)c1CCCC

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1C2 P52895 1/20 0.39
AKR1C1 Q04828 1/20 0.39
ALOX5 P09917 5/20 0.39
ESR1 P03372 2/20 0.39
NPSR1 Q6W5P4 2/20 0.37
NPC1 O15118 1/20 0.37
HPGD P15428 1/20 0.37
MAPK1 P28482 1/20 0.37
HTT P42858 1/20 0.37
RAB9A P51151 1/20 0.37
KDM4E B2RXH2 1/20 0.35
PKM P14618 1/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
PAK1 Q13153 1/20 0.35
HCAR3 P49019 1/20 0.34
HCAR2 Q8TDS4 1/20 0.34
FFAR1 O14842 1/20 0.34
ALDH1A1 P00352 1/20 0.34
LMNA P02545 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5587837 0.96 ALOX5 (0.44) AKR1C2AKR1C1ALOX5ESR1MEN1
SCHEMBL5589284 0.94 ALOX5 (0.47) ALOX5ESR1HCAR2TRPV1
SCHEMBL5587621 0.94 ALOX5 (0.47) ALOX5ESR1HCAR2TRPV1
SCHEMBL5589315 0.94 ALOX5 (0.47) ALOX5ESR1HCAR2TRPV1
SCHEMBL5586883 0.94 ALOX5 (0.47) ALOX5ESR1HCAR2TRPV1
SCHEMBL5588163 0.94 ALOX5 (0.47) ALOX5ESR1HCAR2TRPV1
SCHEMBL5586621 0.91 LDHA (0.37) AKR1C2AKR1C1ALOX5ESR1NPC1
SCHEMBL6253051 0.90 AKR1C2 (0.39) AKR1C2AKR1C1ALOX5ESR1NPSR1
SCHEMBL5677838 0.85 ALOX5 (0.41) ALOX5ESR1NPSR1NPC1HPGD
SCHEMBL5587475 0.84 ALOX5 (0.43) AKR1C2AKR1C1ALOX5ESR1NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7247687-B2 Late transition metal catalysts for olefin polymerization and oligomerization EXXONMOBIL CHEMICAL PATENTS INC. (US) 2007-07-24 US disclosed
EP-1521758-B1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION EXXONMOBIL CHEM PATENTS INC (US) 2006-05-24 EP disclosed
US-20060047094-A1 Late transition metal catalysts for olefin polymerization and oligomerization EXXONMOBIL CHEMICAL PATENTS INC. 2006-03-02 US disclosed
EP-1521758-A1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION Exxonmobil Chemical Patents Inc. (US) 2005-04-13 EP disclosed
WO-2004007509-A1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION EXXONMOBIL CHEMICAL PATENTS INC. (US) 2004-01-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060047094-A1 Late transition metal catalysts for olefin polymerization and oligomerization MLX, LOX, LMTK3 AKR1C2 2588/4885AKR1C1 2546/4885ALOX5 188/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.